Ignite Creation Date:
2024-05-06 @ 3:48 PM
Last Modification Date:
2024-10-26 @ 1:57 PM
Study NCT ID:
NCT04762511
Status:
TERMINATED
Last Update Posted:
2021-06-28
First Post:
2021-02-17
Brief Title:
A Study on the Reactogenicity Safety and Immune Response of a Vaccine Against Herpes Simplex Virus HSV-2 in Healthy Participants Aged 18-40 Years
Sponsor:
Organization:
GlaxoSmithKline